The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
Kevin Noonan of Patent Docs has provided an expert, cogent summary of Myriad’s arguments to enjoin some other providers of testing for BRCA genes. However, Kevin is a steadfast advocate for broad patent claims, so view the analysis with that thought in mind.
Over time, litigators dealing with cancer issues will need to become more attuned to asking plaintiffs and their doctors more questions about their history of viral diseases. Why? As we are slowly lea
The litigation industry is global. The latest example is the start of RoundUp/glyphosate litigation in Australia, as described in this June 3, 2019 article in the Brisbane Times.